Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma.
Mizumura K, Gon Y, Harada N, Yamada S, Fukuda A, Ozoe R, Maruoka S, Abe S, Takahashi K, Tanaka A, Sagara H, Akamatsu T, Shirai T, Masaki K, Fukunaga K, Kobayashi K, Nagase H, Miyahara N, Kanehiro A, Kitamura N, Sugihara N, Kumasawa F, Terada-Hirashima J, Hojo M, Chibana K, Tagaya E.
Mizumura K, et al. Among authors: sugihara n.
Allergol Int. 2024 Sep 13:S1323-8930(24)00087-X. doi: 10.1016/j.alit.2024.08.005. Online ahead of print.
Allergol Int. 2024.
PMID: 39277433
Free article.